Myasthenia gravis (MG) is a rare nerve-muscle disease characterized by bodily weakness and fatigue . This condition occurs when the connection between nerve cells and muscle tissue is broken. This failure is typically due to the body's defenses attacking the meeting place where signals and muscles meet – the neuromuscular junction . Consequently,

Ketoconazole serves as a leading antifungal compound. This potent therapy effectively disrupts a wide spectrum of fungal infections, positioning it a crucial tool in the fight against these detrimental conditions. Its capacity to suppress ergosterol biosynthesis, a critical component of fungal cell membranes, causes in significant reduction of fung